The objective of this survey was to determine both the nature and extent of
regulatory hurdles experienced by companies in seeking Market Authorisation for
medicines in African countries. The target groups for the survey were the PIASA
Export working group and the PIASA Regulatory working group. Specific commercial
issues were avoided for reasons of Competition Law...